Trial Profile
A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Oramed Pharmaceuticals
- 15 Jun 2017 Status changed from recruiting to completed.
- 11 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
- 11 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Apr 2017.